CoMpass Clinical Trial 2025
Auckland Eye is proud to be the first centre in New Zealand participating in the Phase 3 CoMpass clinical trial.
We’re taking part in Round the Bays Auckland 2026 to help raise essential funds for the important work of Glaucoma New Zealand. Our specialists work alongside partners like these to safeguard the vision of New Zealanders.
Glaucoma is a leading general cause of irreversible blindness, often progressing silently with no warning signs whatever. By education, support, and advocacy, Glaucoma NZ is an important partner in educating the public about it, whereas ophthalmology experts are involved in its treatment.
✨ You can make a difference.
When you donate to our fundraiser, you’re contributing to making people with glaucoma aware, diagnosed earlier, and treated better.
👉 Donate here: https://lnkd.in/ggUUKjGp
Every step we take and every contribution we make helps preserve sight today and tomorrow. Thank you for participating in something so important 💙👀

Auckland Eye is proud to be the first centre in New Zealand participating in the Phase 3 CoMpass clinical trial.

Auckland Eye has become the very first site worldwide to recruit and treat a patient in the i-SIGHT2 study.

Auckland Eye is pleased to welcome Dr Bia Kim, a highly trained Cornea and Anterior Segment Specialist, to our team.